Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CollPlant Biotechnologies (NASDAQ:CLGN) through any online brokerage.
Other companies in CollPlant Biotechnologies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
CollPlant Biotechnologies has a consensus price target of $125.00.
The stock price for CollPlant Biotechnologies (NASDAQ: CLGN) is $3.8 last updated October 21, 2026 at 8:27 AM EDT.
There are no upcoming dividends for CollPlant Biotechnologies.
CollPlant Biotechnologies does not have any upcoming earnings scheduled.
There is no upcoming split for CollPlant Biotechnologies.
CollPlant Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.